Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
IQVIA Holdings
NYSE:IQV Community
1
Narratives
written by author
0
Comments
on narratives written by author
19
Fair Values set
on narratives written by author
Create a narrative
IQVIA Holdings
Popular
Undervalued
Overvalued
IQVIA Holdings
WA
Analyst Price Target
Consensus Narrative from 23 Analysts
AI Advancements And New Partnerships Will Improve Future Efficiencies In Life Sciences
Key Takeaways Strategic partnerships and AI advancements in TAS are driving efficiencies, enhancing revenue growth, and improving net margins. Strong backlog and new pharma collaborations indicate robust revenue and potential long-term margin enhancements.
View narrative
US$249.04
FV
23.3% undervalued
intrinsic discount
5.05%
Revenue growth p.a.
Set as Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
23 days ago
author updated this narrative
Your Valuation for
IQV
IQVIA Holdings
Your Fair Value
US$
Current Price
US$191.04
7.1% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
20b
2015
2018
2021
2024
2025
2027
2030
Revenue US$20.0b
Earnings US$1.8b
Advanced
Set as Fair Value